8[5]FDA Guidance for industry and reviewers: Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers[ S]. 2002; 12
9[6]FDA Guidance for Industry: food-effect bioavailability and fed bioequivalence studies[ S]. 2002; 12
8Sen R,Baltimore D.Inducibility of kappa immunoglobulinen-hancer-binding protein NF-kappa B by a posttranslational mech-anism[J].Cell,1986,47(6):921-928.
9Yokozawa T,Dong E,Kawai Y,et al.Protective effect of some flavonoids on the renal cellular membrane[J].Exp Toicol Pathol,1999,51(1):9-14.
